Monsanto Co. (NYSE: MON), the world's largest seed company, is scheduled to release fiscal first quarter earnings before the opening bell on Tuesday, January 8, 2011. Analysts, on average, expect the company to report earnings of 37 cents per share on revenue of $2.64 billion. In the year ago quarter, the company earnings of 23 cents per share on revenue of $2.44 billion.
Monsanto Company provides agricultural products for farmers in the United States and internationally. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. Originally a chemical company, Monsanto has morphed into an agricultural giant, focusing on seeds and crop protection products.
In the preceding fiscal fourth-quarter, the St. Louis, Missouri-based company reported a loss of $229 million, or 42 cents a share, compared with a year-earlier loss of $112 million, or 21 cents a share. On an adjusted basis, the per-share loss was 44 cents, compared with 22 cents in the year-ago quarter. Revenue dropped 6 percent to $2.11 billion from $2.25 billion. Analysts, on average, expected the company to report loss of 42 cents per share on revenue of $3.36 billion.
At its last earnings call in October, Monsanto predicted full-year earnings of $4.18 to $4.32 a share. For calendar 2013, Monsanto anticipates a 5%-10% increase in corn prices, compared to 2012 levels. Free cash flow is expected to be within the $1.7-$1.8 billion range. The net cash provided by operating activities is expected to be in the range of $2.8 billion to $3.1 billion while net cash required by investing activities in the range of $1.1 billion to $1.3 billion. SG&A expenses would be roughly 42.55 billion and R&D expenses roughly $1.53 billion. The company maintains that its Dekalb brand of corn seeds result in a yield advantage of eight bushels per acre over its competitors.
Hugh Grant, chairman and chief executive officer for Monsanto said, "With more waves of innovation and global opportunities than ever before, I'm confident that by building off what we accomplished in 2012 we can achieve steady growth in fiscal year 2013 as we continue to deliver sustainable yield to our farmer customers."
Monsanto expects international sales to account for half of its growth in biotech seeds for fiscal 2013. The company has been expanding rapidly in emerging markets like Argentina, Brazil and other South American countries.
The company possesses a strong pipeline of seed products, which promise significant gains. Moreover, it has an impressive track record of delivering innovations to the marketplace.
Full Disclosure: None.
Monsanto Company provides agricultural products for farmers in the United States and internationally. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. Originally a chemical company, Monsanto has morphed into an agricultural giant, focusing on seeds and crop protection products.
In the preceding fiscal fourth-quarter, the St. Louis, Missouri-based company reported a loss of $229 million, or 42 cents a share, compared with a year-earlier loss of $112 million, or 21 cents a share. On an adjusted basis, the per-share loss was 44 cents, compared with 22 cents in the year-ago quarter. Revenue dropped 6 percent to $2.11 billion from $2.25 billion. Analysts, on average, expected the company to report loss of 42 cents per share on revenue of $3.36 billion.
At its last earnings call in October, Monsanto predicted full-year earnings of $4.18 to $4.32 a share. For calendar 2013, Monsanto anticipates a 5%-10% increase in corn prices, compared to 2012 levels. Free cash flow is expected to be within the $1.7-$1.8 billion range. The net cash provided by operating activities is expected to be in the range of $2.8 billion to $3.1 billion while net cash required by investing activities in the range of $1.1 billion to $1.3 billion. SG&A expenses would be roughly 42.55 billion and R&D expenses roughly $1.53 billion. The company maintains that its Dekalb brand of corn seeds result in a yield advantage of eight bushels per acre over its competitors.
Hugh Grant, chairman and chief executive officer for Monsanto said, "With more waves of innovation and global opportunities than ever before, I'm confident that by building off what we accomplished in 2012 we can achieve steady growth in fiscal year 2013 as we continue to deliver sustainable yield to our farmer customers."
Monsanto expects international sales to account for half of its growth in biotech seeds for fiscal 2013. The company has been expanding rapidly in emerging markets like Argentina, Brazil and other South American countries.
The company possesses a strong pipeline of seed products, which promise significant gains. Moreover, it has an impressive track record of delivering innovations to the marketplace.
Full Disclosure: None.
